We are live on ! Find out more
NGNE icon

Neurogene
NGNE

80 hedge funds and large institutions have $119M invested in Neurogene in 2021 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 25 increasing their positions, 26 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

611% more call options, than puts

Call options by funds: $1.28M | Put options by funds: $180K

0.14% less ownership

Funds ownership: 3.05% → 2.91% (-0.14%)

4% less repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 26

6% less funds holding

Funds holding: 85 → 80 (-5)

25% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 20

37% less capital invested

Capital invested by funds: $187M → $119M (-$68.3M)

Holders
80
Holders Change
-5
Holders Change %
-5.88%
% of All Funds
1.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
25
Reduced
26
Closed
20
Calls
$1.28M
Puts
$180K
Net Calls
+$1.1M
Net Calls Change
+$900K

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$3.34M
2
PPA
Parametric Portfolio Associates
Washington
+$664K
3
Renaissance Technologies
Renaissance Technologies
New York
+$528K
4
JP Morgan Chase
JP Morgan Chase
New York
+$488K
5
Two Sigma Advisers
Two Sigma Advisers
New York
+$366K

Top Sellers

Rank Fund Capital Flow
1
BC
Boxer Capital
California
-$10.9M
2
Alkeon Capital Management
Alkeon Capital Management
New York
-$1.68M
3
GIM
Granahan Investment Management
Massachusetts
-$906K
4
PAMS
Pictet Asset Management (Switzerland)
Switzerland
-$550K
5
Swiss National Bank
Swiss National Bank
Switzerland
-$534K
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$570K -$28K -230 -4%
PPA
27
Parametric Portfolio Associates
Washington
$525K +$664K +5,448 New
Charles Schwab
28
Charles Schwab
California
$428K – – –
D.E. Shaw & Co
29
D.E. Shaw & Co
New York
$305K +$226K +1,858 +142%
Los Angeles Capital Management
30
Los Angeles Capital Management
California
$248K +$53.7K +441 +21%
TI
31
Trexquant Investment
Connecticut
$235K +$87.8K +721 +42%
HPWM
32
Highland Private Wealth Management
Washington
$227K – – –
Goldman Sachs
33
Goldman Sachs
New York
$222K -$437K -3,588 -61%
RhumbLine Advisers
34
RhumbLine Advisers
Massachusetts
$216K -$3.65K -30 -1%
PP
35
PDT Partners
New York
$190K +$114K +934 +90%
SCM
36
Sio Capital Management
New York
$185K – – –
Deutsche Bank
37
Deutsche Bank
Germany
$163K +$73.1K +600 +55%
Susquehanna International Group
38
Susquehanna International Group
Pennsylvania
$144K +$15.3K +126 +9%
Dimensional Fund Advisors
39
Dimensional Fund Advisors
Texas
$142K +$38.4K +315 +27%
Federated Hermes
40
Federated Hermes
Pennsylvania
$124K +$157K +1,287 New
AllianceBernstein
41
AllianceBernstein
Tennessee
$121K -$7.92K -65 -5%
Wells Fargo
42
Wells Fargo
California
$118K +$92K +755 +158%
CGL
43
Clarius Group LLC
Washington
$113K -$487 -4 -0.3%
Acadian Asset Management
44
Acadian Asset Management
Massachusetts
$112K +$143K +1,170 New
Janney Montgomery Scott
45
Janney Montgomery Scott
Pennsylvania
$96K – – –
CSS
46
Cubist Systematic Strategies
Connecticut
$93K +$93.7K +769 +394%
State Board of Administration of Florida Retirement System
47
State Board of Administration of Florida Retirement System
Florida
$92K – – –
California State Teachers Retirement System (CalSTRS)
48
California State Teachers Retirement System (CalSTRS)
California
$90K -$183K -1,501 -62%
AIG
49
American International Group
New York
$90K -$3.41K -28 -3%
Citadel Advisors
50
Citadel Advisors
Florida
$83K -$30.9K -254 -23%
1
2
3 4

NGNE Hedge Fund Activity: Q4 2021 in Review

80 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Neurogene (NGNE) for Q4 2021, worth a combined $119M — down 37% from $187M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of NGNE and 15 opened new positions — a net loss of 5 holders — while 26 trimmed existing stakes and 25 added.

The largest buyer was Millennium Management, adding an estimated $3.34M. The largest seller was Boxer Capital, exiting entirely with an estimated $10.9M sold.

  • 80 institutional investors held Neurogene (NGNE) as of Q4 2021, down from 85 in Q3 2021.
  • Funds reported $119M of Neurogene stock for Q4 2021, down 37% quarter-over-quarter.
  • 15 funds opened new Neurogene positions in Q4 2021 and 20 closed out, a net change of -5 holders.
  • The largest Neurogene buyer in Q4 2021 was Millennium Management, an estimated $3.34M added.
  • The largest Neurogene seller in Q4 2021 was Boxer Capital, an estimated $10.9M sold.

Based on aggregated 13F filings for Q4 2021.